Modeling AEC—New approaches to study rare genetic disorders
- 24 March 2014
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (10) , 2443-2454
Abstract
Ankyloblepharon‐ectodermal defects‐cleft lip/palate (AEC) syndrome is a rare monogenetic disorder that is characterized by severe abnormalities in ectoderm‐derived tissues, such as skin and its appendages. A major cause of morbidity among affected infants is severe and chronic skin erosions. Currently, supportive care is the only available treatment option for AEC patients. Mutations in TP63, a gene that encodes key regulators of epidermal development, are the genetic cause of AEC. However, it is currently not clear how mutations in TP63 lead to the various defects seen in the patients' skin. In this review, we will discuss current knowledge of the AEC disease mechanism obtained by studying patient tissue and genetically engineered mouse models designed to mimic aspects of the disorder. We will then focus on new approaches to model AEC, including the use of patient cells and stem cell technology to replicate the disease in a human tissue culture model. The latter approach will advance our understanding of the disease and will allow for the development of new in vitro systems to identify drugs for the treatment of skin erosions in AEC patients. Further, the use of stem cell technology, in particular induced pluripotent stem cells (iPSC), will enable researchers to develop new therapeutic approaches to treat the disease using the patient's own cells (autologous keratinocyte transplantation) after correction of the disease‐causing mutations.Keywords
Funding Information
- National Institutes of Health (AR054696)
- National Institutes of Health (AR061506)
- National Institutes of Health (AR053892)
- National Foundation for Ectodermal Dysplasias
This publication has 90 references indexed in Scilit:
- Genomic Profiling of a Human Organotypic Model of AEC Syndrome Reveals ZNF750 as an Essential Downstream Target of Mutant TP63The American Journal of Human Genetics, 2012
- ZNF750 Is a p63 Target Gene that Induces KLF4 to Drive Terminal Epidermal DifferentiationDevelopmental Cell, 2012
- Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndromeEMBO Molecular Medicine, 2012
- Advancements in reprogramming strategies for the generation of induced pluripotent stem cellsJournal of Assisted Reproduction and Genetics, 2011
- p63 in Skin Development and Ectodermal DysplasiasJournal of Investigative Dermatology, 2010
- Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologiesTrends in Biotechnology, 2010
- Epidermal patterning and induction of different hair types during mouse embryonic developmentBirth Defects Research Part C: Embryo Today: Reviews, 2009
- ΔNp63 knockdown mice: A mouse model for AEC syndromeAmerican Journal of Medical Genetics Part A, 2009
- Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem CellsCell Stem Cell, 2009
- Sorting Out the p63 Signaling NetworkJournal of Investigative Dermatology, 2008